[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":4113000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PaidInKindInterest_2_Q2_USD":14000.0,"OtherPrepaidExpenseCurrent_0_Q2_USD":174000.0,"OtherNonoperatingExpense_2_Q2_USD":24000.0,"OtherNonoperatingExpense_1_Q2_USD":27000.0,"OtherAssetsCurrent_0_Q2_USD":316025000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":94000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_2_Q2_USD":88000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":112000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":201000.0,"OperatingLeaseLiability_0_Q2_USD":314000.0,"OperatingIncomeLoss_2_Q2_USD":-31537000.0,"OperatingIncomeLoss_1_Q2_USD":-15439000.0,"OperatingExpenses_2_Q2_USD":31537000.0,"OperatingExpenses_1_Q2_USD":15439000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-14284000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":319000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockValue_0_Q2_USD":null,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":6029000.0,"TemporaryEquityDividendsAdjustment_2_Q2_USD":99994000.0,"TemporaryEquityDividendsAdjustment_1_Q2_USD":99994000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":167045000.0,"StockIssuedDuringPeriodValueConversionOfUnits_1_Q2_USD":221721000.0,"StockholdersEquity_0_Q2_USD":311763000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2_Q2_shares":4719605.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments_2_Q2_USD":0.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-86308000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":22547000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":9914000.0,"ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_2_Q2_USD":8000000.0,"RedeemablePreferredStockDividends_2_Q2_USD":99994000.0,"RedeemablePreferredStockDividends_1_Q2_USD":99994000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":67000.0,"ProfitLoss_2_Q2_USD":-31575000.0,"ProfitLoss_1_Q2_USD":-15473000.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_2_Q2_USD":129757000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":167660000.0,"PrepaidInsurance_0_Q2_USD":4578000.0,"NetIncomeLossAttributableToRedeemableNoncontrollingInterest_2_Q2_USD":2109000.0,"NetIncomeLossAttributableToRedeemableNoncontrollingInterest_1_Q2_USD":1191000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":2109000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":1191000.0,"DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance_0_Q2_shares":0.0,"CommonStockSharesOutstanding_0_Q2_shares":61928939.0,"CommonStockSharesIssued_0_Q2_shares":61928939.0,"CommonStockSharesAuthorized_0_Q2_shares":500000000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CashAndCashEquivalentsPeriodIncreaseDecrease_2_Q2_USD":266268000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":309996000.0,"Assets_0_Q2_USD":316537000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":9101990000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":3075000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":2537000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":2537000.0,"AdditionalPaidInCapital_0_Q2_USD":398065000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":26000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":913000.0,"AccruedPayrollTaxesCurrent_0_Q2_USD":849000.0,"AccruedMarketingCostsCurrent_0_Q2_USD":615000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":4113000.0,"AccountsPayableCurrent_0_Q2_USD":348000.0,"DeferredCompensationArrangementWithIndividualSharesIssued_2_Q2_shares":0.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":22661889.0,"DepreciationDepletionAndAmortization_2_Q2_USD":10000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-10.81,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-23149000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-8000000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":297417000.0,"LiabilitiesCurrent_0_Q2_USD":4662000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":316537000.0,"Liabilities_0_Q2_USD":4774000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":19000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":103000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":18000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":212000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":333000.0,"InterestExpense_2_Q2_USD":14000.0,"InterestExpense_1_Q2_USD":7000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":4722000.0,"IncreaseDecreaseInDepositOtherAssets_2_Q2_USD":19000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":145000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":8990000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":5525000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_2_Q2_USD":0.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-5.04,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":11976577.0,"Ticker":"DAWN","CIK":"1845337","name":"DAY ONE BIOPHARMACEUTICALS, INC.","OfficialName":"Day One Biopharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"682620000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210810"}]